Abstract Number: 1891 • 2018 ACR/ARHP Annual Meeting
Patterns of Biosimilar Use in the Rheumatology Informatics System for Effectiveness (RISE) Registry
Background/Purpose: In the U.S., the first biosimilar tumor necrosis inhibitor (TNFi) was approved in 2016. To date, only biosimilars for infliximab are available in the…Abstract Number: 2115 • 2018 ACR/ARHP Annual Meeting
Identification of Systemic Lupus Erythematosus Subgroups Using Electronic Health Record and Genetic Databases
Background/Purpose: Systemic lupus erythematosus (SLE) is a multifactorial disease with genetic and environmental risk factors, and heterogeneous manifestations that encompass a wide range of disease…Abstract Number: 2134 • 2018 ACR/ARHP Annual Meeting
Modifiable Risk Factors and the Development of Psoriatic Arthritis in People with Psoriasis
Background/Purpose: Psoriatic Arthritis (PsA) is a progressive and often destructive joint disease that causes pain, swelling and joint stiffness, and can lead to an impaired…Abstract Number: 206 • 2018 ACR/ARHP Annual Meeting
Impact of International Classification of Diseases 10th Revision Codes and Updated Medical Information on an Existing Rheumatoid Arthritis Phenotype Algorithm Using Electronic Medical Data
Background/Purpose: Electronic medical records (EMRs) are increasingly being utilized for clinical research, where the phenotypes of interest are typically defined by algorithms. Almost a decade…Abstract Number: 2152 • 2018 ACR/ARHP Annual Meeting
A Comparison of the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics Classification (SLICC) Criteria to Detect Patients with Systemic Lupus Erythematosus (SLE) in Electronic Health Record (EHR) Data
Background/Purpose: Systemic Lupus Erythematosus is a systemic autoimmune disease that has diverse manifestations that can occur over a long period of time. The complexity of…Abstract Number: 295 • 2018 ACR/ARHP Annual Meeting
Implementing a Staff Tobacco Cessation Protocol Increases Quit Line Referrals in a Community Rheumatology Practice
Background/Purpose: Smoking remains the leading preventable cause of US mortality and predicts higher incidence, greater severity, and reduced treatment response in many rheumatologic conditions. Despite…Abstract Number: 2174 • 2018 ACR/ARHP Annual Meeting
Self-Report of Fracture History Compared to Fracture Codes from an Electronic Health Record Dataset
Background/Purpose: Self-reported fracture (fx) history data is frequently used in epidemiological studies of osteoporosis. Self-reported fx data may differ from fx history coded in electronic…Abstract Number: 333 • 2018 ACR/ARHP Annual Meeting
Electronic Delivery of Patient-Reported Outcome Questionnaires on Tablet PCs at Clinic Visit: A Feasibility Study
Background/Purpose: Assessment of patient-reported outcomes (PROs) at clinic visits has emerged as an important component to determine disease activity in Rheumatoid Arthritis (RA). However, paper-based…Abstract Number: 2180 • 2018 ACR/ARHP Annual Meeting
Differences in Longitudinal Disease Activity Measures between Research Cohort and Non-Cohort Participants with Rheumatoid Arthritis Using Electronic Health Record Data
Background/Purpose: Research using electronic health records (EHR) may offer advantages over traditional observational studies, including lower costs and greater generalizability to a broader patient population;…Abstract Number: 334 • 2018 ACR/ARHP Annual Meeting
Use of Handheld Device to Enhance Patient Reported Outcome Measure Data Collection in an Academic Rheumatology Practice
Background/Purpose: Patient-reported outcome measures (PROMs) are accepted modalities of gathering patient self-report of their health status in the realms of physical, mental and social well-being.…Abstract Number: 2423 • 2018 ACR/ARHP Annual Meeting
Births to Women with Systemic Lupus Erythematosus Can be Identified Accurately in the Electronic Health Record
Background/Purpose: Studying births in women with systemic lupus erythematosus (SLE) is difficult given its rarity and the challenges of randomized trials. While the electronic health…Abstract Number: 337 • 2018 ACR/ARHP Annual Meeting
Does a Best Practice Alert Improve RA Patient Referral to Preventative Cardiology?
Background/Purpose: RA patients are at about 50% increased risk of cardiovascular disease (CVD)1. Despite this risk, numerous studies show inadequate cardiovascular risk assessment of these…Abstract Number: 2802 • 2018 ACR/ARHP Annual Meeting
Risk of Ischemic Stroke in Veterans with Systemic Sclerosis: A Nationwide Cohort Study
Background/Purpose: Previously thought to involve primarily the microvasculature, systemic sclerosis (SSc) has been increasingly linked to macrovascular disease. Cardiovascular and cerebrovascular disease are responsible for…Abstract Number: 338 • 2018 ACR/ARHP Annual Meeting
Implementation of an Automated Phrase to Increase Awareness of Cardiovascular Risk in Rheumatoid Arthritis Patients in an Urban Fellows Rheumatology Clinic
Background/Purpose: Rheumatoid arthritis (RA) is a significant and well-established risk factor for atherosclerotic cardiovascular disease (ASCVD). Cardiovascular risk stratification is often left to the primary…Abstract Number: 2859 • 2018 ACR/ARHP Annual Meeting
Do Preventive Cardiology Consults Versus Usual Care Improve Cardiovascular Risk Factor Assessment and Management in Patients with Rheumatoid Arthritis?
Background/Purpose: Rheumatoid arthritis (RA) patients have around 50% increased risk of cardiovascular disease (CVD). Both traditional and RA-specific cardiovascular (CV) risk factors contribute to the…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 6
- Next Page »